Back |
home / stock / cdxs / cdxs message board
Subject | By | Source | When |
---|---|---|---|
TEVA supported $CDXS is down to $3.78.. | mlkrborn | investorshub | 02/21/2012 7:53:09 PM |
~ $CDXS ~ Earnings posted, pending or coming | Penny Roger$ | investorshub | 02/07/2012 11:07:43 AM |
Biotech Class Of 2010: IPOs Revisited | surf1944 | investorshub | 01/11/2012 5:06:59 PM |
mark dec 7th on your calendar going to | jensis1 | investorshub | 12/04/2011 6:10:19 AM |
price is going to increase | jensis1 | investorshub | 12/04/2011 6:08:17 AM |
8:46AM On The Wires (WIRES) : Codexis ($CDXS) | surf1944 | investorshub | 10/24/2011 1:44:51 PM |
6. Codexis, Inc. ($CDXS): Develops proprietary biocatalysts for | surf1944 | investorshub | 10/21/2011 3:16:00 PM |
Codexis Presents Carbon Capture Update at DoE/NETL Conference | surf1944 | investorshub | 08/31/2011 1:25:03 PM |
Cleantech IPOs Revisited | surf1944 | investorshub | 07/09/2011 9:23:30 PM |
http://www.secform4.com/insider-trading/1200375.htm | surf1944 | investorshub | 05/21/2011 12:40:06 PM |
Young Clean-Tech IPOs: Still Losing Money | surf1944 | investorshub | 05/21/2011 12:39:03 PM |
Codexis Becomes Target for Suitors Seeking Enzymes, Chief | surf1944 | investorshub | 05/21/2011 12:37:48 PM |
http://www.briefing.com/GeneralContent/Active/Investor/TickerSearch/TickerSearch | surf1944 | investorshub | 05/21/2011 12:36:42 PM |
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an asset purchase agreement with Crosswalk Therapeutics for the Company’s investigational Fabry and Pompe disease compounds. Under...
2024-05-30 07:30:04 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CDXS on May 30, 2024 06:15AM ET. CDXS was trading at $3.19 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy rec...
2024-05-30 07:00:11 ET Kristen Kluska from Cantor Fitzgerald issued a price target of $11.00 for CDXS on 2024-05-30 06:15:00. The adjusted price target was set to $11.00. At the time of the announcement, CDXS was trading at $3.19. CDXS currently trades -34.90% versus its...